Lisa Bisaccia Sells 29,445 Shares of CVS Health Corp (CVS) Stock

CVS Health Corp (NYSE:CVS) EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the sale, the executive vice president now directly owns 15,556 shares in the company, valued at approximately $1,166,700. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of CVS Health Corp (NYSE CVS) opened at $73.41 on Friday. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. CVS Health Corp has a 52 week low of $66.45 and a 52 week high of $84.72. The stock has a market capitalization of $75,609.72, a PE ratio of 15.17, a price-to-earnings-growth ratio of 1.40 and a beta of 0.89.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.01. The business had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.64 EPS. equities analysts predict that CVS Health Corp will post 5.9 earnings per share for the current year.

A number of analysts recently commented on CVS shares. Jefferies Group set a $76.00 price objective on CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Royal Bank of Canada started coverage on CVS Health in a research note on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price objective on the stock. Robert W. Baird reaffirmed a “hold” rating and set a $77.00 price objective on shares of CVS Health in a research note on Friday, October 27th. Leerink Swann set a $85.00 price objective on CVS Health and gave the company a “buy” rating in a research note on Monday, December 4th. Finally, Citigroup set a $76.00 price target on CVS Health and gave the stock a “hold” rating in a research note on Monday, December 4th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $86.35.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in shares of CVS Health by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 76,557,597 shares of the pharmacy operator’s stock valued at $6,159,825,000 after purchasing an additional 1,056,265 shares in the last quarter. FMR LLC lifted its stake in shares of CVS Health by 22.0% in the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock valued at $2,425,920,000 after purchasing an additional 5,446,930 shares in the last quarter. Northern Trust Corp lifted its stake in shares of CVS Health by 5.5% in the 2nd quarter. Northern Trust Corp now owns 15,618,081 shares of the pharmacy operator’s stock valued at $1,256,631,000 after purchasing an additional 807,639 shares in the last quarter. Nordea Investment Management AB lifted its stake in shares of CVS Health by 8.4% in the 2nd quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock valued at $1,138,905,000 after purchasing an additional 1,100,373 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of CVS Health by 4.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 10,856,659 shares of the pharmacy operator’s stock valued at $882,860,000 after buying an additional 430,377 shares during the period. 81.63% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This report was first published by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://www.com-unik.info/2017/12/24/lisa-bisaccia-sells-29445-shares-of-cvs-health-corp-cvs-stock.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Insider Buying and Selling by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit